STOCK TITAN

VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
VolitionRx Limited (VNRX) to host conference call on November 15 at 8:30 a.m. U.S. Eastern Time to discuss third quarter 2023 financial and operating results, and provide a business update. Call details and dial-in information provided. President and CEO, Cameron Reynolds, to host the call along with other key executives.
Positive
  • None.
Negative
  • None.

Conference call to take place on Wednesday November 15 at 8:30 a.m. U.S Eastern Time

HENDERSON, Nev., Nov. 8, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Wednesday, November 15 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the third quarter 2023, in addition to providing a business update. Details of this event can also be found below.

Event:   VolitionRx Limited Third Quarter 2023 Earnings and Business Update Conference Call 
Date:     Wednesday, November 15, 2023
Time:    8:30 a.m. U.S. Eastern Time

U.S. & Canada Dial-in:1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID: 13742634

Cameron Reynolds, President and Group Chief Executive Officer of Volition, will host the call along with Terig Hughes, Group Chief Financial Officer, Dr. Tom Butera, Chief Executive Officer of Volition Veterinary Diagnostics Development LLC, Dr. Andrew Retter, Medical Consultant to Volition and Scott Powell, Executive Vice President, Investor Relations. The call will provide an update on important events which have taken place in the third quarter of 2023 and upcoming milestones.

A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website at https://ir.volition.com. In addition, a telephone replay of the call will be available until November 29, 2023. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13742634.

About Volition

Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also improve their quality of life.

Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.

The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document.  Such website address is included in this document as an inactive textual reference only.

Media Enquiries:

Louise Batchelor/Debra Daglish, Volition, mediarelations@volition.com +44 (0)7557 774620

 

Cision View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-third-quarter-2023-earnings-conference-call-and-business-update-301981625.html

SOURCE VolitionRx Limited

FAQ

What is the purpose of VolitionRx Limited's conference call on November 15?

The conference call is to discuss the company's financial and operating results for the third quarter of 2023 and provide a business update.

Who will be hosting the conference call for VolitionRx Limited?

The call will be hosted by President and CEO, Cameron Reynolds, along with other key executives of the company.

Where can I find the live audio webcast of the conference call?

The live audio webcast will be available on the investor relations page of Volition's corporate website at https://ir.volition.com.

How long will the telephone replay of the conference call be available?

The telephone replay of the call will be available until November 29, 2023.

VolitionRx Limited

NYSE:VNRX

VNRX Rankings

VNRX Latest News

VNRX Stock Data

56.42M
62.70M
23.92%
7.97%
0.6%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
HENDERSON

About VNRX

volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.